• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中谷氨酸能去神经支配及可能的异常代谢证据。

Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.

作者信息

Procter A W, Palmer A M, Francis P T, Lowe S L, Neary D, Murphy E, Doshi R, Bowen D M

机构信息

Institute of Neurology, London, England.

出版信息

J Neurochem. 1988 Mar;50(3):790-802. doi: 10.1111/j.1471-4159.1988.tb02983.x.

DOI:10.1111/j.1471-4159.1988.tb02983.x
PMID:3339353
Abstract

Excitatory dicarboxylic amino acids previously have been ascribed several functions in the brain. Here their total concentration and proposed neurochemical markers of neurotransmitter function have been measured in brain from patients with Alzheimer's disease (AD) and controls. Specimens were obtained antemortem (biopsy) approximately 3 years after emergence of symptoms and promptly (less than 3 h) postmortem some 10 years after onset. Early in the disease a slight elevation in aspartic acid concentration of cerebral cortex was observed in the patients with AD. A reduction in glutamic acid concentration of a similar magnitude was found. It is argued that this, together with a decrease in CSF glutamine content and lack of change in the phosphate-activated brain glutaminase activity of tissue, reflects an early metabolic abnormality. Later in the disease evidence of glutamatergic neurone loss is provided by the finding that in many regions of the cerebral cortex the Na+-dependent uptake of D-[3H]aspartic acid was almost always lowest in AD subjects compared with control when assessed by a method designed to minimise artifacts and epiphenomena. Release of endogenous neurotransmitters from human brain tissue postmortem did not appear to have the characteristics of that from human tissue antemortem and rat brain.

摘要

兴奋性二羧酸氨基酸此前已被认为在大脑中具有多种功能。在此,我们测定了阿尔茨海默病(AD)患者和对照组大脑中它们的总浓度以及推测的神经递质功能的神经化学标志物。标本在症状出现后约3年进行生前获取(活检),并在发病后约10年迅速(少于3小时)进行死后获取。在疾病早期,AD患者大脑皮质中天冬氨酸浓度略有升高。同时发现谷氨酸浓度有类似程度的降低。有人认为,这与脑脊液谷氨酰胺含量的降低以及组织中磷酸激活脑谷氨酰胺酶活性缺乏变化一起,反映了早期代谢异常。在疾病后期,通过一种旨在尽量减少假象和附带现象的方法评估发现,与对照组相比,AD患者大脑皮质许多区域中依赖钠的D-[3H]天冬氨酸摄取几乎总是最低的,这为谷氨酸能神经元丢失提供了证据。死后从人脑组织释放内源性神经递质似乎不具有生前人体组织和大鼠脑组织释放神经递质的特征。

相似文献

1
Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.阿尔茨海默病中谷氨酸能去神经支配及可能的异常代谢证据。
J Neurochem. 1988 Mar;50(3):790-802. doi: 10.1111/j.1471-4159.1988.tb02983.x.
2
Topographical distribution of neurochemical changes in Alzheimer's disease.阿尔茨海默病中神经化学变化的地形分布。
J Neurol Sci. 1988 Apr;84(2-3):125-40. doi: 10.1016/0022-510x(88)90118-9.
3
Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.老年精神分裂症患者背外侧前额叶皮质中谷氨酸和γ-氨基丁酸代谢改变的影响。
Am J Psychiatry. 2002 Jul;159(7):1165-73. doi: 10.1176/appi.ajp.159.7.1165.
4
Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients.正常人和阿尔茨海默病患者脑室脑脊液及大脑中的氨基酸和转氨酶活性
Neurosci Lett. 2005 Nov 4;388(1):49-53. doi: 10.1016/j.neulet.2005.06.030.
5
Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?阿尔茨海默病的神经元基础是胆碱能的还是谷氨酸能的?
FASEB J. 1990 Jul;4(10):2745-52. doi: 10.1096/fasebj.4.10.2165009.
6
Control of glutaminase activity in rat brain cortex in vitro: influence of glutamate, phosphate, ammonium, calcium and hydrogen ions.体外大鼠大脑皮层谷氨酰胺酶活性的调控:谷氨酸、磷酸盐、铵、钙和氢离子的影响
Brain Res. 1981 Mar 16;208(2):363-77. doi: 10.1016/0006-8993(81)90564-3.
7
Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease.生前脑氨基酸浓度表明阿尔茨海默病中富含谷氨酸的神经元发生选择性退化。
Neuroscience. 1990;38(3):571-7. doi: 10.1016/0306-4522(90)90051-5.
8
N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study.阿尔茨海默病大脑中的N-乙酰-L-天冬氨酸及其他氨基酸代谢物:一项初步的质子核磁共振研究
Neurology. 1992 Aug;42(8):1578-85. doi: 10.1212/wnl.42.8.1578.
9
A postmortem study of amino acid neurotransmitters in Alzheimer's disease.阿尔茨海默病中氨基酸神经递质的尸检研究。
Ann Neurol. 1986 Nov;20(5):616-21. doi: 10.1002/ana.410200510.
10
Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.阿尔茨海默病两个阶段脑组织中的γ-氨基丁酸浓度。
Brain. 1988 Aug;111 ( Pt 4):785-99. doi: 10.1093/brain/111.4.785.

引用本文的文献

1
Glutamatergic and GABAergic metabolite levels in Alzheimer's disease: a systematic review and meta-analysis.阿尔茨海默病中谷氨酸能和γ-氨基丁酸能代谢物水平:一项系统评价和荟萃分析。
BMC Neurol. 2025 Aug 26;25(1):344. doi: 10.1186/s12883-025-04375-2.
2
Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.在阿尔茨海默病的临床和病理进展过程中,皮质默认模式网络中的囊泡谷氨酸转运体变化。
J Alzheimers Dis. 2023;94(1):227-246. doi: 10.3233/JAD-221063.
3
Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy.
神经退行性疾病中能量代谢和氨基酸代谢紊乱的代谢组学特征:早期诊断和治疗监测的前景
Metabolites. 2023 Mar 1;13(3):369. doi: 10.3390/metabo13030369.
4
EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review.EAAT2作为阿尔茨海默病的治疗研究靶点:一项系统综述。
Front Neurosci. 2022 Aug 10;16:952096. doi: 10.3389/fnins.2022.952096. eCollection 2022.
5
Is the Brain Undernourished in Alzheimer's Disease?阿尔茨海默病患者的大脑是否营养不良?
Nutrients. 2022 Apr 29;14(9):1872. doi: 10.3390/nu14091872.
6
Integrative genomic analysis of PPP3R1 in Alzheimer's disease: a potential biomarker for predictive, preventive, and personalized medical approach.阿尔茨海默病中PPP3R1的综合基因组分析:一种用于预测、预防和个性化医疗方法的潜在生物标志物。
EPMA J. 2021 Nov 15;12(4):647-658. doi: 10.1007/s13167-021-00261-2. eCollection 2021 Dec.
7
Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease.胆碱能、肾上腺素能和谷氨酸能网络调节与阿尔茨海默病认知功能障碍的关系。
Int J Mol Sci. 2021 Feb 25;22(5):2283. doi: 10.3390/ijms22052283.
8
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease.高效液相色谱法测定阿尔茨海默病患者脑、脑脊液和血清中 L-谷氨酸、L-谷氨酰胺和甘氨酸的含量。
Amino Acids. 2021 Mar;53(3):435-449. doi: 10.1007/s00726-021-02943-7. Epub 2021 Feb 22.
9
A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy.与阿尔茨海默病相关的众多信号通路及其在 AD 发病机制和治疗中的作用。
Med Res Rev. 2021 Sep;41(5):2689-2745. doi: 10.1002/med.21719. Epub 2020 Aug 11.
10
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.肝酶改变与阿尔茨海默病诊断、认知、神经影像学指标和脑脊液生物标志物的关联。
JAMA Netw Open. 2019 Jul 3;2(7):e197978. doi: 10.1001/jamanetworkopen.2019.7978.